To participate in this trial, please register your clinic for an educational session and learn more about Compass, the new National Cervical Screening Program and be eligible for 40 QI & CPD points.
Benefits of participation
As part of the trial, we will provide accredited training and ongoing phone support from a team of Liaison Physicians with access to pathologists, cytologists and scientists with extensive expertise in cervical cancer screening.
Accredited education sessions
GPs participating in the trial are eligible to take part in the Compass ALM and earn 40
category 1 QI&CPD points and Women’s Health points for the current 2017-2019 triennium.
Education sessions take 1 hour and are a compulsory component of the Compass Trial ALM.
These sessions will prepare GPs and their practices for the renewed National Cervical Screening Program (NCSP) and enable Practitioners to recruit eligible women for Compass.
We offer education sessions in person or via webinar for clinics interested in recruiting for the Compass Trial. To register your interest, please provide the following details.
- Explanation of the natural history of HPV infection and its role in cervical cancer
- Implementation of safe and appropriate practice systems around recall, reminders and follow-up of women recruited into the trial
- Interpretation of new screening results and recommend appropriate follow-up
- Introduction of the new National Cervical Screening Program which commences
A comprehensive clinical support service run by Liaison Physicians is available for participating GPs which includes assistance with:
- Interpreting Cervical Screening Test (CST) results and new terminology
- Sampling techniques and the new cervical screening test
- Follow-up advice and new management recommendations
- Cervical screening history information.